Chronic myeloid and lymphocytic leukemias in the elderly: public health challenges in early detection and long-term care

Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) predominantly affect older adults, presenting unique challenges in early detection and long-term management. The growing elderly population globally has intensified the public health burden of these chronic leukemias, particularly in low-resource settings. This narrative review synthesizes current evidence on the epidemiology, clinical features, early detection, and long-term care of CML and CLL in elderly populations, with a focus on public health implications and region-specific considerations. A structured literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar, including studies published from 2000 to 2025. Risk-based screening protocols, economic burden, and disparities in low-resource settings were emphasized. CML and CLL incidence increases with age, with median diagnosis ages of 67 and 70 years, respectively. Early detection is often delayed due to non-specific symptoms, limited molecular diagnostics, and sociocultural factors. Long-term management is complicated by comorbidities, treatment adherence challenges, and fragmented care systems. Evidence-based strategies, including risk-based screening, multidisciplinary care, and community-based interventions, improve outcomes. In low-resource settings such as Zimbabwe, disparities in diagnostic capacity, drug availability, and supportive care significantly affect disease outcomes. Economic analyses highlight that early detection and guideline-adherent monitoring are cost-effective, reducing complications and optimizing resource utilization. Effective management of CML and CLL in elderly populations requires integrated strategies combining early detection, personalized care, and health system strengthening. Tailored interventions addressing both clinical and socioeconomic determinants of health, particularly in low-resource environments, are essential to improve survival, quality of life, and cost efficiency.

Authors

Institutions

Publication Details

Journal
Annals of Medicine and Surgery
Published
2026-01-08
DOI
https://doi.org/10.1097/ms9.0000000000004671
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chronic myeloid and lymphocytic leukemias in the elderly: public health challenges in early detection and long-term care

Aksha Parray, Emmanuel Ifeanyi Obeagu
Annals of Medicine and Surgery
Chronic Lymphocytic Leukemia Research
article

Chronic myeloid and lymphocytic leukemias in the elderly: public health challenges in early detection and long-term care

Aksha Parray, Emmanuel Ifeanyi Obeagu
article en

Abstract

Chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) predominantly affect older adults, presenting unique challenges in early detection and long-term management. The growing elderly population globally has intensified the public health burden of these chronic leukemias, particularly in low-resource settings. This narrative review synthesizes current evidence on the epidemiology, clinical features, early detection, and long-term care of CML and CLL in elderly populations, with a focus on public health implications and region-specific considerations. A structured literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar, including studies published from 2000 to 2025. Risk-based screening protocols, economic burden, and disparities in low-resource settings were emphasized. CML and CLL incidence increases with age, with median diagnosis ages of 67 and 70 years, respectively. Early detection is often delayed due to non-specific symptoms, limited molecular diagnostics, and sociocultural factors. Long-term management is complicated by comorbidities, treatment adherence challenges, and fragmented care systems. Evidence-based strategies, including risk-based screening, multidisciplinary care, and community-based interventions, improve outcomes. In low-resource settings such as Zimbabwe, disparities in diagnostic capacity, drug availability, and supportive care significantly affect disease outcomes. Economic analyses highlight that early detection and guideline-adherent monitoring are cost-effective, reducing complications and optimizing resource utilization. Effective management of CML and CLL in elderly populations requires integrated strategies combining early detection, personalized care, and health system strengthening. Tailored interventions addressing both clinical and socioeconomic determinants of health, particularly in low-resource environments, are essential to improve survival, quality of life, and cost efficiency.

Annals of Medicine and SurgeryVol. 88(2)
University of the Witwatersrand (ZA), Akal University (IN), Africa University (ZW)
Openalex Percentile: Top 93%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.